We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+11.46%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$79.9B
AUM Growth
+$16.7B
Cap. Flow
+$9.74B
Cap. Flow %
12.19%
Top 10 Hldgs %
13.34%
Holding
4,935
New
829
Increased
1,631
Reduced
1,587
Closed
796

Sector Composition

Rank Sector Weight
1 Healthcare 10.45%
2 Technology 8.65%
3 Financials 8.6%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASIX icon
4151
AdvanSix
ASIX
$454M
-38,228
Closed -$983K
ASMB icon
4152
Assembly Biosciences
ASMB
$718M
-933
Closed -$110K
ASND icon
4153
CALL
Ascendis Pharma A/S
ASND
$16.5B
-10,900
Closed -$1.05M
ASPS icon
4154
Altisource Portfolio Solutions
ASPS
$62.2M
-2,756
Closed -$445K
ASTE icon
4155
Astec Industries
ASTE
$1B
-6,900
Closed -$214K
ASYS icon
4156
Amtech Systems
ASYS
$245M
-11,372
Closed -$60K
AUPH icon
4157
CALL
Aurinia Pharmaceuticals
AUPH
$2.2B
-163,000
Closed -$870K
AVAV icon
4158
AeroVironment
AVAV
$7.53B
-10,183
Closed -$545K
AVNS
4159
DELISTED
Avanos Medical
AVNS
-10,879
Closed -$394K
AVNS
4160
PUT
DELISTED
Avanos Medical
AVNS
-20,000
Closed -$749K
AVTX icon
4161
Avalo Therapeutics
AVTX
$1.03B
-32
Closed -$305K
AXTA icon
4162
PUT
Axalta
AXTA
$7.72B
-78,500
Closed -$2.37M
AYI icon
4163
PUT
Acuity Brands
AYI
$10.1B
-20,000
Closed -$2.69M
AZN icon
4164
CALL
AstraZeneca
AZN
$259B
-225,300
Closed -$20.1M
BAC.PRL icon
4165
Bank of America Series L
BAC.PRL
$3.97B
-241
Closed -$361K
BBCP icon
4166
Concrete Pumping Holdings
BBCP
$474M
-24,180
Closed -$95K
BBIO icon
4167
BridgeBio Pharma
BBIO
$15.8B
-37,382
Closed -$802K
BBVA icon
4168
Banco Bilbao Vizcaya Argentaria
BBVA
$161B
-19,966
Closed -$103K
BBY icon
4169
CALL
Best Buy
BBY
$18.4B
-5,300
Closed -$365K
BCBP icon
4170
BCB Bancorp
BCBP
$157M
-14,884
Closed -$191K
BCSF icon
4171
Bain Capital Specialty
BCSF
$786M
-151,192
Closed -$2.81M
BDJ icon
4172
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.72B
-13,557
Closed -$124K
BFH icon
4173
Bread Financial
BFH
$4.04B
-274,653
Closed -$28.1M
BGT icon
4174
BlackRock Floating Rate Income Trust
BGT
$323M
-11,682
Closed -$143K
BGY icon
4175
BlackRock Enhanced International Dividend Trust
BGY
$530M
-57,515
Closed -$312K

Similar funds

Israel Englander's Q4 2019 Portfolio in Review

As of Q4 2019, Israel Englander held 4,935 positions worth $79.9B, up 26% from $63.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Israel Englander deployed $9.74B of net new capital in Q4 2019, opening 829 new positions and adding to 1,631 existing holdings. Its largest new stake was International Flavors & Fragrances: 535,214 shares worth $69.1M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $326M trimmed.

  • Israel Englander's largest Q4 2019 buy was International Flavors & Fragrances: 535,214 shares worth $69.1M.
  • Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $3.83B increase.
  • Israel Englander's biggest Q4 2019 reduction was Lowe's Companies, cutting an estimated $326M.
  • Israel Englander fully exited Celgene Corp in Q4 2019, selling an estimated $414M.
  • Israel Englander's ten largest holdings make up 13% of its $79.9B portfolio in Q4 2019.
  • Israel Englander opened 829 new positions and closed 796 in Q4 2019.
  • Israel Englander's portfolio value rose 26% quarter-over-quarter to $79.9B.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.